TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments

Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) Investor Securities Class Action Lawsuit 04/15/2022

  • If you purchased a shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH), you have certain options and for certain investors are short and strict deadlines running. Deadline: June 14, 2022. NASDAQ: AUPH investors should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Lawsuit Overview

April 15, 2022 - An investor in shares of Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Aurinia Pharmaceuticals Inc. in connection with certain allegedly false and misleading statements made between May 7, 2021 and February 25, 2022,. Canada based Aurinia...



You must register (for free) or login to view the entire case.

Click here to Sign In or Register (for a free account)